Stryker to Buy Spine Technology From VertiFlex

Share on Facebook
San Clemente, Calif.-based VertiFlex plans to sell some of its non-core spine technology to Stryker.

The minimally invasive spine device maker aims to use funds from the sale to advance its platform for spinal stenosis treatments, according to the release. The scale and scope of the deal are not disclosed, and will include cash and contingent payments as well as a long-term licensing agreement.

VertiFlex is currently conducting an investigational device exemption trial for its Superion Interspinous Spacer system.

More Articles on Supply Chain:
41 Orthopedic & Spine Devices Receive FDA 510(k) Clearance in February
Dr. Stephen Cook Named to Precision Spine Board of Directors
Nexxt Spine Consolidates, Relocates Headquarters


© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

New from Becker's ASC Review

Need a new supply management strategy? 5 key steps

Read Now